Data‐Driven Feedback Identifies Focused Ultrasound Exposure Regimens for Improved Nanotheranostic Targeting of the Brain
Authors:
- Hohyun LeeHLHohyun Lee
- Victor MenezesVMVictor Menezes
- Shiqin ZengSZShiqin Zeng
- Chulyong KimCKChulyong Kim
- Cynthia M. BasemanCBCynthia M. Baseman
- Jae Hyun KimJKJae Hyun Kim
- Samhita PadmanabhanSPSamhita Padmanabhan
- Pranav PremdasPPPranav Premdas
- Naima DjeddarNDNaima Djeddar
- Anton BryksinABAnton Bryksin
- Nikhil PandeyNPNikhil Pandey
- Pavlos AnastasiadisPAPavlos Anastasiadis
Open Access
- 7 January 2026
- journal article
- Published by Wiley in Advanced Science
- Vol. 13 (13) , e17834
Abstract
The blood‐brain barrier (BBB) renders the delivery of nanomedicine in the brain ineffective and the detection of circulating disease‐related DNA from the brain unreliable. Here, we demonstrate that microbubble‐enhanced focused ultrasound (MB‐FUS) mediated BBB opening, supported by large‐data models predict sonication regimens for safe and effective BBB opening. Importantly, a closed‐loop MB‐FUS controller augmented by machine learning (ML‐CL) expands the treatment window, as compared to conventional controllers, by persistently and proactively maximizing the BBB permeability while preventing tissue damage. By successfully scaling up from mice to rats and from healthy to diseased brains (glioma), ML‐CL rendered the BBB permeable to large nanoparticles and markedly improved the release and detection of reporter gene DNA from tumors in blood. Together, our findings reveal the potential of data‐driven feedback to support the development of next‐generation AI‐powered ultrasound systems for safe, robust, and efficient nanotheranostic targeting and treatment of brain diseases.Keywords
Funding Information
- National Institutes of Health (R37CA239039)
- Focused Ultrasound Foundation (AWD 004091)
This publication has 95 references indexed in Scilit:
- Towards controlled drug delivery in brain tumors with microbubble-enhanced focused ultrasoundAdvanced Drug Delivery Reviews, 2021
- Biomarkers and focused ultrasound: the future of liquid biopsy for brain tumor patientsJournal of Neuro-Oncology, 2021
- The “Liquid Biopsy”: the Role of Circulating DNA and RNA in Central Nervous System TumorsCurrent Neurology and Neuroscience Reports, 2016
- In Vivo Cell Tracking with Bioluminescence ImagingNuclear Medicine and Molecular Imaging, 2014
- Ultrasound-mediated blood–brain barrier disruption for targeted drug delivery in the central nervous systemAdvanced Drug Delivery Reviews, 2014
- Drug delivery to the central nervous system by polymeric nanoparticles: What do we know?Advanced Drug Delivery Reviews, 2014
- Blood–brain barrier structure and function and the challenges for CNS drug deliveryJournal of Inherited Metabolic Disease, 2013
- Use of Single‐Site‐Functionalized PEG Dendrons To Prepare Gene Vectors that Penetrate Human Mucus BarriersAngewandte Chemie International Edition, 2013
- Optimization of enzyme–substrate pairing for bioluminescence imaging of gene transfer using Renilla and Gaussia luciferasesThe Journal of Gene Medicine, 2010
- The Forced Bubble1994